How alcohol affects the way drugs are processed in the body
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
This study looks at how drinking alcohol affects the way your body processes medications, focusing on certain enzymes that help break down drugs, to help make sure that people who drink can use their medications safely and effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington State University NIH-funded |
| Lab location | 1 site (Pullman, United States) |
| Project ID | NIH-10911893 on NIH RePORTER |
What this research studies
This research investigates how alcohol consumption influences the metabolism of drugs in the body, focusing on a group of enzymes known as cytochrome P450. By examining the interactions between alcohol and these enzymes, the study aims to understand the broader implications for drug efficacy and safety. The researchers will analyze how changes in the composition of these enzymes due to alcohol consumption can affect drug metabolism and lead to potential adverse effects. This work is crucial for improving patient safety and optimizing drug therapies for individuals who consume alcohol.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who consume alcohol and are taking medications that may interact with alcohol.
Not a fit: Patients who do not consume alcohol or are not on any medications that could interact with alcohol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer drug prescriptions and better management of alcohol-related health issues.
How similar studies have performed: Previous research has shown that understanding enzyme interactions can significantly improve drug safety, indicating that this approach has potential for success.
Where this research is happening
Pullman, United States
- Washington State University — Pullman, United States (Active)
Researchers
- Principal investigator: Davydov, Dmitri R — Washington State University
- Study coordinator: Davydov, Dmitri R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.